Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making.

Fabiana PerroneFrancesco FacchinettiBenedetta PellegrinoRoberta MinariLetizia GnettiCinzia AzzoniLorena BottarelliNicoletta CampaniniJuan Francisco Grau-BejarAnna MingozziValeria CognigniMarcello Tiseo

Published in: Tumori (2024)

This case highlights that an attentive and critical evaluation of molecular reports is key for the tailoring of treatment algorithms at the patient-level scale.

Keyphrases

decision making
machine learning
emergency department
deep learning
single molecule
dna damage